Aldeyra Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2013 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Aldeyra Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2013 to Q4 2024.
  • Aldeyra Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 59.5M shares, a 0.92% increase year-over-year.
  • Aldeyra Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 59.5M shares, a 0.92% increase from 2023.
  • Aldeyra Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 58.9M shares, a 0.92% increase from 2022.
  • Aldeyra Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 58.4M shares, a 8.08% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 59.5M +542K +0.92% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-28
Q3 2024 59.5M +540K +0.92% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 59.4M +623K +1.06% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 59.4M +623K +1.06% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 58.9M +537K +0.92% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-28
Q3 2023 59M +532K +0.91% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 58.8M +490K +0.84% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 58.8M +494K +0.85% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 58.4M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 58.5M +439K +0.76% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 58.3M +4.02M +7.41% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 58.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 58M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 54.3M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2016 9.71M +3.05M +45.7% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-09
Q4 2015 8.63M +4.82M +126% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-30
Q3 2015 9.71M +4.15M +74.5% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-13
Q2 2015 8.4M +4.66M +125% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-14
Q1 2015 6.67M +6.34M +1937% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 3.82M +3.5M +1099% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 5.57M +5.25M +1654% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 3.74M +3.42M +1089% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 327K +12.9K +4.12% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 318K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-23
Q3 2013 317K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 314K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 314K Jan 1, 2013 Mar 31, 2013 10-Q 2014-06-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.